EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

Autor: KOWAL BIELECKA O, LANDEWÉ R, AVOUAC J, CHWIESKO S, MINIATI I, CZIRJAK L, CLEMENTS P, DENTON C, FARGE D, FLIGELSTONE K, FÖLDVARI I, FURST DE, MÜLLER LADNER, U, SEIBOLD J, SILVER RM, TAKEHARA K, GARAY TOTH B, TYNDALL A, VAN, DEN HOOGEN F, WIGLEY F, ZULIAN F, MATUCCI CERINIC M., VALENTINI, Gabriele

Publikováno v: Annals of the rheumatic diseases, 68(5), 620-628. BMJ Publishing Group

Purpose:The optimal treatment of systemic sclerosis (SSc) is a challenge because the pathogenesis of SSc is unclear and it is an uncommon and clinically heterogeneous disease affecting multiple organ systems. The aim of the European League Against Rh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b38774f8de3fb440ae41b73a1a093710
http://hdl.handle.net/11591/186585

Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group.

Autor: Jaeger VK; Department of Rheumatology, University Hospital Basel, Basel., Distler O; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland., Maurer B; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland., Czirják L; Department of Rheumatology and Immunology, Medical Center, University of Pécs, Pécs, Hungary., Lóránd V; Department of Rheumatology and Immunology, Medical Center, University of Pécs, Pécs, Hungary., Valentini G; Department of Rheumatology, Second University of Naples, Naples, Italy., Vettori S; Department of Rheumatology, Second University of Naples, Naples, Italy., Del Galdo F; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds., Abignano G; NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds., Denton C; Department of Rheumatology, University College London, Royal Free Hospital, London, UK., Nihtyanova S; Department of Rheumatology, University College London, Royal Free Hospital, London, UK., Allanore Y; Department of Rheumatology, University of Paris Descartes, Paris, France., Avouac J; Department of Rheumatology, University of Paris Descartes, Paris, France., Riemekasten G; Department of Rheumatology, University Clinic Schleswig-Holstein, Lübeck., Siegert E; Department of Rheumatology and Clinical Immunology, University Hospital Charité., Huscher D; German Rheumatism Research Centre, Berlin, Germany., Matucci-Cerinic M; Department of Rheumatology, University of Florence, Florence, Italy., Guiducci S; Department of Rheumatology, University of Florence, Florence, Italy., Frerix M; Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Kerckhoff Clinic Bad Nauheim, Bad Nauheim, Germany., Tarner IH; Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Kerckhoff Clinic Bad Nauheim, Bad Nauheim, Germany., Garay Toth B; Federation of European Scleroderma Associations Aisbl, Budapest, Hungary., Fankhauser B; new-win SW Solutions AG, Suhr, Switzerland., Umbricht J; new-win SW Solutions AG, Suhr, Switzerland., Zakharova A; VA Nasonova Institute of Rheumatology, Moscow, Russian Federation., Mihai C; Department of Internal Medicine and Rheumatology, Dr Ion Cantacuzino Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Cozzi F; Rheumatology Unit, Department of Medicine, University of Padova, Padova, Italy., Yavuz S; Department of Rheumatology, University of Marmara, Altunizade-Istanbul, Turkey., Hunzelmann N; Department of Dermatology, University of Cologne, Cologne, Germany., Rednic S; Clinica Reumatologie, University of Medicine & Pharmacy, Cluj-Napoca, Romania., Vacca A; II Chair of Rheumatology, University of Cagliari-Policlinico Universitario, Monserrato, Italy., Schmeiser T; Department of Rheumatology and Immunology, Krankenhaus St Josef, Wuppertal, Germany., Riccieri V; Divisione di Reumatologia, Università di Roma La Sapienza, Roma, Italy., García de la Peña Lefebvre P; Servicio de Reumatología, Hospital Universitario Madrid Norte Sanchinarro, Madrid, Spain., Gabrielli A; Istituto di Clinica Medica Generale, Ematologia ed Immunologia Clinica, Università Politecnica delle Marche, Ancona, Italy., Krummel-Lorenz B; Endokrinologikum Frankfurt, Frankfurt, Germany., Martinovic D; Division of Rheumatology, University Hospital of Split, Split, Croatia., Ancuta C; Rheumatology 2 Department, Clinical Rehabilitation Hospital, University of Medicine and Pharmacy 'Grigore T. Popa', Iasi, Romania., Smith V; Faculty of Internal Medicine, Ghent University, Ghent, Belgium., Müller-Ladner U; Department of Rheumatology and Clinical Immunology, Justus-Liebig University Giessen, Kerckhoff Clinic Bad Nauheim, Bad Nauheim, Germany., Walker UA; Department of Rheumatology, University Hospital Basel, Basel.

Publikováno v: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2018 Mar 01; Vol. 57 (3), pp. 441-450.

Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy).

Autor: Coi, Alessio¹ (AUTHOR) alessio.coi@ifc.cnr.it, Barsotti, Simone² (AUTHOR), Santoro, Michele¹ (AUTHOR), Almerigogna, Fabio³ (AUTHOR), Bargagli, Elena⁴ (AUTHOR), Caproni, Marzia^5,6 (AUTHOR), Emmi, Giacomo⁷ (AUTHOR), Frediani, Bruno⁸ (AUTHOR), Guiducci, Serena⁹ (AUTHOR), Matucci Cerinic, Marco⁹ (AUTHOR), Mosca, Marta² (AUTHOR), Parronchi, Paola⁷ (AUTHOR), Prediletto, Renato^1,10 (AUTHOR), Selvi, Enrico¹¹ (AUTHOR), Simonini, Gabriele¹² (AUTHOR), Tavoni, Antonio Gaetano¹³ (AUTHOR), Bianchi, Fabrizio^1,10 (AUTHOR), Pierini, Anna^1,10 (AUTHOR), Rare Diseases Working Group (CORPORATE AUTHOR)

Publikováno v: Orphanet Journal of Rare Diseases. 2/17/2021, Vol. 16 Issue 1, p1-13. 13p.

Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry.

Autor: Shanmugam, Victoria K., Frech, Tracy M., Steen, Virginia D., Hummers, Laura K., Shah, Ami A., Bernstein, Elana J., Khanna, Dinesh, Gordon, Jessica K., Castelino, Flavia V., Chung, Lorinda, Hant, Faye N., Startup, Emily, VanBuren, John M., Evnin, Luke B., Assassi, Shervin

Publikováno v: Clinical Rheumatology; Jan2020, Vol. 39 Issue 1, p93-102, 10p, 6 Charts

Selected Immune Disorders and Disability

Autor: National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Selected Immune Disorders and Disability

The U.S. Social Security Administration (SSA) administers the Social Security Disability Insurance program and the Supplemental Security Income program. As part of their process, immune system disorders are evaluated under Listing of Impairments 14.0